Showing 4811-4820 of 20470 results for "".
- Emergency Department Buprenorphine Trial: Abstract Reporthttps://reachmd.com/news/emergency-department-buprenorphine-trial-abstract-report/2486662/Key Takeaways A randomized emergency department trial compared extended-release injectable vs sublingual buprenorphine, not referral-based care. Treatment engagement at 7 days was similar between groups (40.5% vs 38.5%), with no significant difference.
- CKD Linked to Higher Complication Risk After Mohs Surgeryhttps://reachmd.com/news/ckd-linked-to-higher-complication-risk-after-mohs-surgery/2486676/Chronic kidney disease (CKD) was associated with increased postoperative complications following Mohs micrographic surgery (MMS), according to results of a study published as a Research Letter in the Journal of Drugs in Dermatology Authors evaluated
- Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Findshttps://reachmd.com/news/cell-assisted-lipotransfer-shows-potential-in-facial-and-breast-applications-review-finds/2486650/Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerati
- Meta-Analysis Links Hidradenitis Suppurativa With Higher Cancer Riskhttps://reachmd.com/news/meta-analysis-links-hidradenitis-suppurativa-with-higher-cancer-risk/2486646/A systematic review and meta-analysis of cancer incidence in hidradenitis suppurativa reported that hidradenitis suppurativa was associated with a higher overall cancer risk than gener
- Elraglusib Plus Chemotherapy Shows Survival Benefit in Pancreatic Cancerhttps://reachmd.com/news/elraglusib-plus-chemotherapy-shows-survival-benefit-in-pancreatic-cancer/2486644/In a randomized phase 2 study in metastatic pancreatic cancer, investigators reported longer survival with chemotherapy plus e
- Ultrasound Technologies Expand Role in Noninvasive Facial Rejuvenationhttps://reachmd.com/news/ultrasound-technologies-expand-role-in-noninvasive-facial-rejuvenation/2486640/Ultrasound-based energy devices continue to play an expanding role in noninvasive facial and neck rejuvenation, according to a recent review published online in Facial Plastic Surgery. The authors examine the evolution of high-intensity focused ultrasound (HIFU) into newer technologies s
- TONIC to Evaluate Early Nutrition After Emergency Abdominal Surgeryhttps://reachmd.com/news/tonic-early-nutrition-emergency-abdominal-surgery/2486631/Key takeaways: The TONIC trial is evaluating whether early parenteral nutrition after emergency abdominal surgery improves recovery and reduces complications. Results could directly influence postoperative nutritional guidelines in emergency surgery.</
- Stent Procedure Eases Post-Thrombotic Syndrome After DVThttps://reachmd.com/news/stent-post-thrombotic-syndrome-dvt/2486632/Key Takeaways In a randomized trial, severe post-thrombotic syndrome was less common at six months in the endovascular-treatment group (iliac vein stenting plus enhanced antithrombotic therapy) than in the standard-treatment group. The study enrolled p
- Epicutis Reports 8-Week Clinical Findings for New Hydrobiome Serumhttps://reachmd.com/news/epicutis-reports-8-week-clinical-findings-for-new-hydrobiome-serum/2486634/Epicutis has introduced Hydrobiome Serum, a new professional skincare product positioned for redness, congestion, and barrier disruption. The formulation centers on TCP, a proprietary isoprenyl cysteine compound developed by Signum Biosciences, and is paired with sodium tocopheryl phosphate, a wa
- Acquisition Broadens Newmedical’s Scar Care and Skincare Platformhttps://reachmd.com/news/strategic-acquisition-broadens-newmedicals-scar-care-and-skincare-platform/2486628/Newmedical Technology, Inc. announced its acquisition of Derma Made®, marking a strategic expansion of its dermatology and aesthetics portfolio, according to a news release from the company. The transaction will meld Newmedica